Atlas Venture Life Science Advisors

Latest statistics and disclosures from Atlas Venture Life Science Advisors's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are KYMR, DYN, SION, IRON, QTTB, and represent 98.37% of Atlas Venture Life Science Advisors's stock portfolio.
  • Reduced shares in these 3 stocks: DAWN (-$60M), KYMR (-$6.8M), GBIO.
  • Sold out of its positions in DAWN, GBIO.
  • Atlas Venture Life Science Advisors was a net seller of stock by $-71M.
  • Atlas Venture Life Science Advisors has $790M in assets under management (AUM), dropping by -8.68%.
  • Central Index Key (CIK): 0001917529

Tip: Access up to 7 years of quarterly data

Positions held by Atlas Venture Life Science Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Atlas Venture Life Science Advisors

Atlas Venture Life Science Advisors holds 6 positions in its portfolio as reported in the March 2026 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Kymera Therapeutics Common Stock (KYMR) 48.3 $381M 4.6M 83.29
 View chart
Dyne Therapeutics Common Stock (DYN) 21.0 $166M 9.1M 18.13
 View chart
Sionna Therapeutics Common Stock (SION) 15.2 $120M 3.0M 40.09
 View chart
Disc Medicine Common Stock (IRON) 12.3 $97M 1.5M 63.94
 View chart
Q32 Bio Common Stock (QTTB) 1.7 $13M 2.1M 6.42
 View chart
Korro Bio Common Stock (KRRO) 1.6 $13M 1.1M 11.32
 View chart

Past Filings by Atlas Venture Life Science Advisors

SEC 13F filings are viewable for Atlas Venture Life Science Advisors going back to 2022

View all past filings